Current concepts of management in radiotherapy for head and neck squamous-cell cancer
Authors:
- Yungan TaoYTYungan Tao
- Antoine LusinchiALAntoine Lusinchi
- Jean BourhisJean Bourhis
- 1 April 2009
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 45 (4-5) , 402-408
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patientsRadiotherapy and Oncology, 2009
- Recent Advances in Head and Neck CancerNew England Journal of Medicine, 2008
- Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An UpdateInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Cetuximab combined with radiotherapy: An alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck?European Journal of Cancer, 2007
- EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 updateEuropean Journal of Cancer, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysisThe Lancet, 2006
- Chemo-radiotherapy in head and neck cancerAnnals of Oncology, 2006
- Palifermin for Oral Mucositis after Intensive Therapy for Hematologic CancersNew England Journal of Medicine, 2004
- The EGFR as a target for anticancer therapy—focus on cetuximabEuropean Journal of Cancer, 2001